Sub-acute Exercise Following Sport-Related Concussion

September 11, 2020 updated by: Phillip Worts, Florida State University

The Short- And Long-Term Effects Of Submaximal Aerobic Exercise On Recovery Following Sport-Related Concussion In High School Student-Athletes

Determine the safety and efficacy of sub-maximal aerobic exercise during the subacute phase of recovery following sport-related concussion.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The main objective of the proposed study is to determine is exercise during the first 3-7 days following a sport-related concussion can help improve the systemic neurological dysfunction following a concussion while examining the safety and efficacy of a 20-minute, low- to moderate-intensity (40-60% of HRMAX) controlled treadmill aerobic exercise as a therapeutic modality to improve cardiovascular, psychological, vestibulo-ocular, autonomic, and cognitive function.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32308
        • Tallahassee Orthopedic Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria (concussed):

  • high school student-athlete
  • suffered a diagnosed concussion
  • evaluated between Day 3 and Day 7 since injury

Inclusion Criteria (healthy):

  • high school student-athlete
  • no diagnosed concussion within the last year
  • matched with concussion participant for age and gender

Exclusion Criteria:

  • physical limitation prohibiting treadmill walking
  • reports dizziness or lightheadedness
  • presents with any contraindication for exercise participation as defined by American College of Cardiology (ACC), American Heart Association (AHA), or American College of Sports Medicine (ACSM) guidelines.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise

Concussed participants will participate in a single 20' bout of treadmill walking at either 40% or 60% of the age-predicted HRmax.

Healthy participants will participate in a single 20' bout of treadmill walking at either 40% or 60% of the age-predicted HRmax.

HR-controlled treadmill walking
Other Names:
  • Aerobic exercise
No Intervention: Seated Control

Concussed participants will participate in a single 20' treatment session of seated rest.

Healthy participants will participate in a single 20' treatment session of seated rest.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Recovery
Time Frame: The number of days from injury to full medical clearance up to 365 days. 80% of adolescent athletes fully recover in less than 28 days.
Clinical recovery is defined as the duration from the time of injury to the time a patient has received full clearance without restriction.
The number of days from injury to full medical clearance up to 365 days. 80% of adolescent athletes fully recover in less than 28 days.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Heart rate variability (HRV)
Time Frame: HRV will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
The RR Interval will be extracted from the heart rate monitoring system.
HRV will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
Blood Pressure (SBP & DBP)
Time Frame: SBP & DBP will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
SBP & DBP will be recorded with an automated auscultatory BP system
SBP & DBP will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
Ocular Dysfunction
Time Frame: The King-Devick (K-D) will be administered before and within 5 minutes after the acute 20 minute "treatment"
Improvements in ocular dysfunction will be defined as a decrease in errors or reading time
The King-Devick (K-D) will be administered before and within 5 minutes after the acute 20 minute "treatment"
Vestibular Dysfunction
Time Frame: The Vestibular / Ocular Motor Screening (VOMS) will be administered before and within 5 minutes after the acute 20 minute "treatment"
Improvements in vestibular dysfunction will be defined as a decrease in symptom provocation or pretest symptom reporting
The Vestibular / Ocular Motor Screening (VOMS) will be administered before and within 5 minutes after the acute 20 minute "treatment"
Rating of Perceived Exertion (RPE)
Time Frame: RPE will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
Borg's CR-15 will be utilized to quantifying perceived intensity of exercise
RPE will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
Concussion Symptoms
Time Frame: Symptoms will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
All 22 symptoms from the Post-concussion symptom scale (PCSS) as measured on a Likert scale from 0 (not present) to 6 (severe)
Symptoms will be captured for 10 minutes before, 20 minutes during, and after 25 minutes post "treatment".
Exercise Bout Completion Rates
Time Frame: Completion will be determined and recorded at the end of the acute 20 minute treatment.
The rate of completion will be defined as the ability for the participant to finish the "treatment" without early termination.
Completion will be determined and recorded at the end of the acute 20 minute treatment.
Incidence of Persistent Postconcussion symptoms >28 days
Time Frame: The duration in days will be calculated from the day injury to the day full clearance up to 1 year.
Persistent symptoms duration will be categorized as either ≤28 days or > 28 days.
The duration in days will be calculated from the day injury to the day full clearance up to 1 year.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 2, 2017

Primary Completion (Actual)

March 1, 2019

Study Completion (Actual)

July 1, 2020

Study Registration Dates

First Submitted

March 28, 2018

First Submitted That Met QC Criteria

June 28, 2018

First Posted (Actual)

July 2, 2018

Study Record Updates

Last Update Posted (Actual)

September 16, 2020

Last Update Submitted That Met QC Criteria

September 11, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • RF02521 - TOC

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sport-related Concussion

Clinical Trials on Exercise

Subscribe